Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats
Open Access
- 1 March 2001
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 120 (4) , 975-983
- https://doi.org/10.1053/gast.2001.22529
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosisJournal of Hepatology, 1998
- Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive ratsHepatology, 1996
- Short‐term cardiovascular effects of somatostatin in patients with cirrhosisLiver International, 1995
- The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosisJournal of Hepatology, 1994
- Superior mesenteric artery blood flow in man measured with intra-arterial Doppler catheters: Effect of octreotideJournal of Hepatology, 1993
- Somatostatin-induced contraction mediated by endothelial TXA2 production in canine cerebral arteriesLife Sciences, 1993
- POSTSYNAPTIC α‐ADRENORECEPTOR POPULATIONS IN SEVERAL VASCULAR SYSTEMS OF THE ANAESTHETIZED RATJournal of Autonomic Pharmacology, 1984
- SomatostatinNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.Journal of Clinical Investigation, 1977